Literature DB >> 31240120

Is prophylaxis for osteoporosis indicated after acute spinal cord injury?

Yannis Dionyssiotis1.   

Abstract

Spinal cord injury (SCI)-related osteoporosis is common complication in people with tetraplegia or paraplegia. Studies have shown that sublesional regions are severely demineralized. Loss of bone and sequential fractures are major problems in people with SCI that lead to further immobilization and decreasing quality of life. Despite extensive research mechanisms of this bone impairment are inadequately understood. This article discusses basics of bone metabolism physiopathology along with pharmaceutical prevention and treatment approaches to manage acute SCI-related bone loss.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31240120      PMCID： PMC6461754          DOI： 10.1038/s41394-019-0167-y

Source DB:  PubMed          Journal:  Spinal Cord Ser Cases        ISSN： 2058-6124


  21 in total

1.  Intravenous pamidronate attenuates bone density loss after acute spinal cord injury.

Authors:  P W Nance; O Schryvers; W Leslie; S Ludwig; J Krahn; D Uebelhart
Journal:  Arch Phys Med Rehabil       Date:  1999-03       Impact factor: 3.966

Review 2.  Bone loss in spinal cord-injured patients: from physiopathology to therapy.

Authors:  L Maïmoun; C Fattal; J-P Micallef; E Peruchon; P Rabischong
Journal:  Spinal Cord       Date:  2006-04       Impact factor: 2.772

3.  Effect of pamidronate administration on bone in patients with acute spinal cord injury.

Authors:  William A Bauman; Jill M Wecht; Steven Kirshblum; Ann M Spungen; Nancy Morrison; Christopher Cirnigliaro; Ernest Schwartz
Journal:  J Rehabil Res Dev       Date:  2005 May-Jun

4.  Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury.

Authors:  J S Bubbear; A Gall; F R I Middleton; M Ferguson-Pell; R Swaminathan; R W Keen
Journal:  Osteoporos Int       Date:  2010-04-01       Impact factor: 4.507

5.  Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.

Authors:  P Major; A Lortholary; J Hon; E Abdi; G Mills; H D Menssen; F Yunus; R Bell; J Body; E Quebe-Fehling; J Seaman
Journal:  J Clin Oncol       Date:  2001-01-15       Impact factor: 44.544

6.  Cyclical etidronate: its effect on bone density in patients with acute spinal cord injury.

Authors:  E G Pearson; P W Nance; W D Leslie; S Ludwig
Journal:  Arch Phys Med Rehabil       Date:  1997-03       Impact factor: 3.966

Review 7.  Osteoporosis in individuals with spinal cord injury.

Authors:  William A Bauman; Christopher P Cardozo
Journal:  PM R       Date:  2014-08-27       Impact factor: 2.298

8.  Longitudinal study of the bone mineral content and of soft tissue composition after spinal cord section.

Authors:  E Wilmet; A A Ismail; A Heilporn; D Welraeds; P Bergmann
Journal:  Paraplegia       Date:  1995-11

Review 9.  Immobilization osteoporosis in paraplegia.

Authors:  A N Elias; G Gwinup
Journal:  J Am Paraplegia Soc       Date:  1992-07

10.  Effects of tiludronate on bone loss in paraplegic patients.

Authors:  D Chappard; P Minaire; C Privat; E Berard; J Mendoza-Sarmiento; H Tournebise; M F Basle; M Audran; A Rebel; C Picot
Journal:  J Bone Miner Res       Date:  1995-01       Impact factor: 6.741
View more
  2 in total

1.  A pulse survey: assessment and management of bone loss in spinal cord injury.

Authors:  Yannis Dionyssiotis; Ruth Marshall; Michael D Stillman; Leslie R Morse; Anastasia-Christina Rapidi
Journal:  Spinal Cord Ser Cases       Date:  2021-02-11

2.  Body composition and bone mineral density in athletes with a physical impairment.

Authors:  Valentina Cavedon; Marco Sandri; Ilaria Peluso; Carlo Zancanaro; Chiara Milanese
Journal:  PeerJ       Date:  2021-05-10       Impact factor: 2.984
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.